These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin. Rojo F, González-Navarrete I, Bragado R, Dalmases A, Menéndez S, Cortes-Sempere M, Suárez C, Oliva C, Servitja S, Rodriguez-Fanjul V, Sánchez-Pérez I, Campas C, Corominas JM, Tusquets I, Bellosillo B, Serrano S, Perona R, Rovira A, Albanell J. Clin Cancer Res; 2009 May 15; 15(10):3530-9. PubMed ID: 19417026 [Abstract] [Full Text] [Related]
17. YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer. Jiang D, Qiu T, Peng J, Li S, Tala, Ren W, Yang C, Wen Y, Chen CH, Sun J, Wu Y, Liu R, Zhou J, Wu K, Liu W, Mao X, Zhou Z, Chen C. Cell Death Differ; 2022 Jun 11; 29(6):1283-1295. PubMed ID: 35022570 [Abstract] [Full Text] [Related]
18. Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1). Chen CC, Hardy DB, Mendelson CR. J Biol Chem; 2011 Dec 16; 286(50):43091-102. PubMed ID: 22020934 [Abstract] [Full Text] [Related]